Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?
{{output}}
Purpose of review: This review summarizes recent evidence on the use of glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) agonists in the management of short bowel syndrome (SBS), with a focus on emerging therap... ...
